BackRayzeBio Overview

RayzeBio Accounts Payable

Latest accounts payable for RYZB: $2.2M.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$2.24M

Peer average

Loading

RayzeBio Accounts Payable History

Loading

RayzeBio vs. peers: Accounts Payable Comparison

Loading

RayzeBio Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

RayzeBio (RYZB) FAQ

As of the most recent data (September 2023), RYZB shows a accounts payable of $2.2M. Scroll down for historical charts and peer comparison views.

Tracking RYZB's accounts payable over time shows whether RayzeBio is scaling, shrinking, or reshaping that part of the business. The current reading is $2.2M Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this accounts payable page, Stockcircle has RayzeBio's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect accounts payable (currently $2.2M) with ownership activity and broader fundamentals.